Read + Share
Amedeo Smart
Independent Medical Education
Chen T, Yu T, Zhuang S, Geng Y, et al. Upregulation of CXCL1 and LY9 contributes to BRCAness in ovarian cancer and mediates response to PARPi and immune checkpoint blockade. Br J Cancer 2022 May 26. pii: 10.1038/s41416-022-01836.PMID: 35618786
Email
LinkedIn
Facebook
Twitter
Privacy Policy